Hollow Brook Wealth Management LLC Has $312,000 Stock Holdings in The Clorox Company (NYSE:CLX)

Hollow Brook Wealth Management LLC increased its position in shares of The Clorox Company (NYSE:CLXFree Report) by 11.7% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,913 shares of the company’s stock after purchasing an additional 200 shares during the quarter. Hollow Brook Wealth Management LLC’s holdings in Clorox were worth $312,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Mizuho Securities USA LLC increased its stake in shares of Clorox by 46,877.8% in the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after buying an additional 4,490,421 shares in the last quarter. Van ECK Associates Corp raised its position in shares of Clorox by 1,715.5% in the 2nd quarter. Van ECK Associates Corp now owns 1,461,207 shares of the company’s stock valued at $199,411,000 after acquiring an additional 1,380,724 shares during the period. Nuance Investments LLC boosted its position in shares of Clorox by 150.6% during the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock worth $218,035,000 after purchasing an additional 960,094 shares in the last quarter. Wulff Hansen & CO. raised its stake in Clorox by 13,547.0% during the 2nd quarter. Wulff Hansen & CO. now owns 440,116 shares of the company’s stock worth $60,063,000 after buying an additional 436,891 shares during the period. Finally, International Assets Investment Management LLC lifted its holdings in Clorox by 424.9% during the third quarter. International Assets Investment Management LLC now owns 538,576 shares of the company’s stock worth $877,390,000 after acquiring an additional 435,971 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at $2,229,719.92. This represents a 11.40 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.57% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on CLX shares. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and upped their price target for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Evercore ISI cut their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research report on Monday, October 14th. BNP Paribas upgraded Clorox to a “strong sell” rating in a report on Friday, September 6th. Citigroup boosted their price target on Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Finally, Barclays raised their target price on shares of Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research note on Friday, November 1st. Five analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, Clorox presently has an average rating of “Hold” and a consensus target price of $155.00.

Read Our Latest Stock Analysis on Clorox

Clorox Stock Performance

Shares of Clorox stock opened at $167.17 on Monday. The company’s 50 day moving average price is $163.09 and its two-hundred day moving average price is $149.47. The firm has a market capitalization of $20.69 billion, a P/E ratio of 58.25, a P/E/G ratio of 3.09 and a beta of 0.41. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.35.

Clorox (NYSE:CLXGet Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter in the prior year, the firm earned $0.49 EPS. The business’s revenue for the quarter was up 27.0% compared to the same quarter last year. On average, equities analysts forecast that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 2.92%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio is presently 170.04%.

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Further Reading

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.